We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UPST:NASDAQUpstart Holdings, Inc. Analysis

Data as of 2026-05-07 - not real-time

$29.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Upstart is trading around $29, which sits below its 20‑day SMA of 31.84 and just above the 50‑day SMA of 28.89, with a clear support zone near 26.43 and resistance around 35.80. Technicals are mixed: the MACD shows a bearish divergence (line below signal), the RSI at 44 signals a neutral stance, and the 30‑day volatility of 68% combined with a beta of 2.9 points to pronounced price swings. Fundamentally, revenue is expanding at a robust 44.6% year‑over‑year and gross margins remain high at 82.7%, yet operating margins are razor‑thin (0.9%) and cash flow is negative, while debt‑to‑equity sits near 270, highlighting balance‑sheet strain. Valuation metrics are contradictory: a trailing P/E of 70.7 dwarfs the industry average of 16.5, suggesting overvaluation, but a forward P/E of 8.9 hints at potential earnings upside.
Recent market chatter shows a short‑term rally to the low $30s, driven by a 12.9% surge ahead of earnings and a new partnership with Justice Federal Credit Union, but the backdrop includes an emerging securities‑fraud class action alleging false AI claims. The Fear & Greed Index at 90.9 (Extreme Greed) underscores heightened investor enthusiasm, which, together with the stock’s high volatility and legal cloud, creates a volatile near‑term environment while medium‑term growth narratives remain compelling.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and neutral RSI suggest limited upside
  • High short‑term volatility and recent price rally
  • Pending class‑action lawsuit adds legal uncertainty

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth and high gross margins
  • Forward P/E near 9 indicates earnings improvement
  • Partnership expansion broadening loan origination network

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Elevated debt load versus cash reserves
  • Potential regulatory scrutiny of AI credit models
  • Sustained growth potential in AI‑driven lending if profitability improves

Key Metrics & Analysis

Financial Health

Revenue Growth44.60%
Profit Margin4.21%
P/E Ratio70.7
ROE7.01%
ROA1.77%
Debt/Equity269.84
P/B Ratio3.6
Op. Cash Flow$-267536000
Free Cash Flow$-312582368
Industry P/E16.5

Technical Analysis

TrendNeutral
RSI43.9
Support$26.43
Resistance$35.80
MA 20$31.84
MA 50$28.89
MA 200$46.26
MACDBearish
VolumeStable
Fear & Greed Index90.93

Valuation

Target Price$40.60
Upside/Downside40.00%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.89
Volatility68.46%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.